Image alt tag

Error!

There was a problem contacting the server. Please try after sometime.

Sorry, we are unable to process your request.

Error!

We're sorry, but the Insights and Intelligence Tool is temporarily unavailable

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Error!

We're sorry, but the Literature Center checkout function is temporarily unavailable.

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

A verification Email Has Been Sent

An email verification email has been sent to .
Follow the instructions to complete the email validation process.

I have not received my verification email

Check your SPAM mailbox and make sure that twelcome@lordabbett.com is allowed to send you mail.

I'm still having trouble

If you're still having trouble verifying your email address. feel free to contact us.

1-888-522-2388
clientservices@lordabbett.com


OK

We're sorry. We found no record of the email address you provided.

Register For a LordAbbett.com Account
Using Your Email Address.

  • Registered Financial Advisors gain access to:
  • Our data mining tool, Insight & Intelligence
  • Best in-class practice management content
  • Educational events, videos and podcasts.
  • The Lord Abbett Review - Subscribe now!

Registered but Having Problems?

If you believe you are registered and are having problems verifying your email address, feel free to contact us.

1-888-522-2388 clientservices@lordabbett.com

Terms & Condition

These Terms of Use ("Terms of Use") are made between the undersigned user ("you") and Lord, Abbett & Co. ("we" or "us"). They become effective on the date that you electronically execute these Terms of Use ("Effective Date").

A. You are a successful financial consultant that markets securities, including the Lord Abbett Family of Funds;

B. We have developed the Lord Abbett Intelligence System (the "Intelligence System"), a state of the art information resource that we make available to a limited community of broker/dealers through the Internet at a secure Web site (the "LAIS Site"); and

C. We wish to provide access to the Intelligence System to you as an information tool responsive to the demands of your successful business pursuant to these Terms of Use. Accordingly, you and we, intending to be legally bound, hereby agree as follows:]

1. Overview. · Scope. These Terms of Use (which we may amend from time to time) govern your use of the Intelligence System. · Revisions; Changes. We may amend these Terms of Use at any time by posting amended Terms of Use ("Amended Terms of Use") on the LAIS Site. Any Amended Terms of Use will become effective immediately upon posting. Your use of the Intelligence System after any Amended Terms of Use become effective will be deemed to constitute your acceptance of those Amended Terms of Use.We may modify or discontinue the Intelligence System at any time, temporarily or permanently, with or without notice to you. Purpose of the Intelligence System. The Intelligence System is intended to be an information resource that you may use to contribute to your business research. The Intelligence System is for broker/dealer use only; it is not to be used with the public in oral, written or electronic form. The information on the Intelligence System and LAIS Site is for your information only and is neither the tax, legal or investment advice of Lord Abbett or its third-party sources nor their recommendation to purchase or sell any security.

2. Your Privileges. · Personal Use. Your use of the Intelligence System is a nontransferable privilege granted by us to you and that we may deny, suspend or revoke at any time, with or without cause or notice. · Access to and Use of the Intelligence System. The User ID and password (together, an "Access ID") issued by us to you (as subsequently changed by you from time to time) is for your exclusive access to and use of the Intelligence System. You will: (a) be responsible for the security and use of your Access ID, (b) not disclose your Access ID to anyone and (c) not permit anyone to use your Access ID. Any access or use of the Intelligence System through the use of your Access ID will be deemed to be your actions, for which you will be responsible. · Required Technology. You must provide, at your own cost and expense, the equipment and services necessary to access and use the Intelligence System. At any time, we may change the supporting technology and services necessary to use the Intelligence System. · Availability. We make no guarantee that you will be able to access the Intelligence System at any given time or that your access will be uninterrupted, error-free or free from unauthorized security breaches.

3. Rights in Data. Our use of information collected from you will be in accordance with our Privacy Policy posted on the LAIS Site. Our compliance with our Privacy Policy will survive any termination of these Terms of Use or of your use of the Intelligence System.

4. Your Conduct in the Use of the Intelligence System. You may access, search, view and store a personal copy of the information contained on the LAIS Site for your use as a broker/dealer. Any other use by you of the Intelligence System and the information contained on the LAIS Site these Terms of Use is strictly prohibited. Without limiting the preceding sentence, you will not: · Engage in or permit any reproduction, copying, translation, modification, adaptation, creation of derivative works from, distribution, transmission, transfer, republication, compilation or decompilation, reverse engineering, display, removal or deletion of the Intelligence System, any portion thereof, or any data, content or information provided by us or any of our third-party sources in any form, media or technology now existing or hereafter developed, that is not specifically authorized under these Terms of Use.

· Remove, obscure or alter any notice, disclaimer or other disclosure affixed to or contained within the Intelligence System, including any copyright notice, trademark and other proprietary rights notices and any legal notices regarding the data, content or information provided through the Intelligence System.

· Create a hyperlink to, frame or use framing techniques to enclose any information found anywhere on the LAIS Site without our express prior written consent.

· Impersonate any person, or falsely state or otherwise misrepresent his or her affiliation with any person in connection with any use of the Intelligence System.

· Breach or attempt to breach the security of the Intelligence System or any network, servers, data, or computers or other hardware relating to or used in connection with the Intelligence System; nor (b) use or distribute through the Intelligence System software or other tools or devices designed to interfere with or compromise the privacy, security or use of the Intelligence System by others or the operations or assets of any person.

· Violate any applicable law, including, without limitation, any state federal securities laws. 5. Your Representations and Warranties. You hereby represent and warrant to us, for our benefit, as of the time of these Terms of Use and for so long as you continue to use the Intelligence System, that (a) you are, and will continue to be, in compliance with these Terms of Use and any applicable laws and (b) you are authorized to provide to us the information we collect, as described in our Privacy Policy.

6. Disclaimer of Warranties.

· General Disclaimers.

THE INTELLIGENCE SYSTEM, THE LAIS SITE AND ALL DATA, INFORMATION AND CONTENT ON THE LAIS SITE ARE PROVIDED "AS IS" AND “AS AVAILABLE” AND WITHOUT ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND. WITHOUT LIMITING THE PRECEDING SENTENCE, LORD ABBETT, ITS AFFILIATES, AGENTS, THIRD-PARTY SUPPLIERS AND LICENSORS, AND THEIR RESPECTIVE EMPLOYEES, CONTRACTORS, DIRECTORS, OFFICERS AND SHAREHOLDERS (COLLECTIVELY, THE “LORD ABBETT GROUP”) EXPRESSLY DISCLAIM ALL WARRANTIES, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NONINFRINGEMENT. YOU EXPRESSLY AGREE THAT YOUR USE OF THE LAIS SITE, THE INTELLIGENCE SYSTEM, AND THE DATA, INFORMATION AND CONTENT PRESENTED THERE ARE AT YOUR SOLE RISK AND THAT THE LORD ABBETT GROUP WILL NOT BE RESPONSIBLE FOR ANY (A) ERRORS OR INACCURACIES IN THE DATA, CONTENT AND INFORMATION ON THE LAIS SITE AND THE INTELLIGENCE SYSTEM OR (B) ANY TERMINATION, SUSPENSION, INTERRUPTION OF SERVICES, OR DELAYS IN THE OPERATION OF THE LAIS SITE OR THE INTELLIGENCE SYSTEM.

· Disclaimer Regarding Investment Research.

THE INTELLIGENCE SYSTEM INCORPORATES DATA, CONTENT AND INFORMATION FROM VARIOUS SOURCES THAT WE BELIEVE TO BE ACCURATE AND RELIABLE. HOWEVER, THE LORD ABBETT GROUP MAKES NO CLAIMS, REPRESENTATIONS OR WARRANTIES AS TO THE ACCURACY, TIMELINESS, COMPLETENESS OR TRUTHFULNESS OF SUCH DATA, CONTENT AND INFORMATION. YOU EXPRESSLY AGREE THAT YOU ARE RESPONSIBLE FOR INDEPENDENTLY VERIFYING YOUR INVESTMENT RESEARCH PRIOR TO FORMING YOUR INVESTMENT DECISIONS OR RENDERING INVESTMENT ADVICE. THE LORD ABBETT GROUP WILL NOT BE LIABLE FOR ANY INVESTMENT DECISION MADE BY YOU OR ANY OTHER PERSON BASED UPON THE DATA, CONTENT AND INFORMATION PROVIDED THROUGH THE INTELLIGENCE SYSTEM OR ON THE LAIS SITE.

· Survival.

THIS SECTION 6 SHALL SURVIVE ANY TERMINATION OF THESE TERMS OF USE OR YOUR USE OF THE INTELLIGENCE SYSTEM..

7. Limitations on Liability.

NONE OF THE MEMBERS OF THE LORD ABBETT GROUP WILL BE LIABLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, SPECIAL OR EXEMPLARY DAMAGES (INCLUDING LOSS OF PROFITS, LOSS OF USE, TRANSACTION LOSSES, OPPORTUNITY COSTS, LOSS OF DATA, OR INTERRUPTION OF BUSINESS) RESULTING FROM, ARISING OUT OF OR IN ANY WAY RELATING TO THE INTELLIGENCE SYSTEM, THE LAIS SITE OR YOUR USE THEREOF, EVEN IF THE LORD ABBETT GROUP HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS SECTION 7 WILL SURVIVE ANY TERMINATION OF THESE TERMS OF USE OR YOUR USE OF THE INTELLIGENCE SYSTEM.

8. Miscellaneous Provisions.

· Governing Law. This Agreement will governed by and construed in accordance with the laws of the State of New York, without giving effect to applicable conflicts of law principles.

THE UNIFORM COMPUTER INFORMATION TRANSACTIONS ACT OR ANY VERSION THEREOF, ADOPTED BY ANY STATE, IN ANY FORM ("UCITA") WILL NOT APPLY TO THESE TERMS OF USE. TO THE EXTENT THAT UCITA IS APPLICABLE, THE PARTIES HEREBY AGREE TO OPT OUT OF THE APPLICABILITY OF UCITA PURSUANT TO THE OPT-OUT PROVISION(S) CONTAINED THEREIN.

The Intelligence System is not intended to be used by consumers, nor are the consumer protection laws of any jurisdiction intended to apply to the Intelligence System. You agree to initiate and maintain any action, suit or proceeding relating to these Terms of Use or arising out of the use of the Intelligence System exclusively in the courts, state and federal, located in or having jurisdiction over New York County, New York.

YOU HEREBY CONSENT TO THE PERSONAL JURISDICTION AND VENUE OF THE COURTS, STATE AND FEDERAL, LOCATED IN OR HAVING JURISDICTION OVER NEW YORK COUNTY, NEW YORK. YOU AGREE THAT YOU WILL NOT OBJECT TO A PROCEEDING BROUGHT IN YOUR LOCAL JURISDICTION TO ENFORCE AN ORDER OR JUDGMENT OBTAINED IN NEW YORK.

· Relationship of Parties. The parties to these Terms of Use are independent contractors and nothing in these Terms of Use will be construed as creating an employment relationship, joint venture, partnership, agency or fiduciary relationship between the parties.

· Notice. All notices provided under these Terms of Use will be in writing and will be deemed effective: (a) when delivered personally, (b) when received by electronic delivery, (c) one business day after deposit with a commercial overnight carrier specifying next day delivery, with written verification of receipt, or (d) three business days after having been sent by registered or certified mail, return receipt requested. We will only accept notices from you in English and by conventional mail addressed to: General Counsel Lord, Abbett & Co. 90 Hudson Street Jersey City, N.J. 07302-3973 We may give you notice by conventional mail or electronic mail addressed to the last mail or electronic mail address transmitted by you to us.

· Third-Party Beneficiaries. The members of the Lord Abbett Group are third-party beneficiaries of the rights and benefits provided to us under these Terms of Use. You understand and agree that any right or benefit available to us or any member of the Lord Abbett Group hereunder will also be deemed to accrue to the benefit of, and may be exercised directly by, any member of the Lord Abbett Group to the extent applicable.

· Survival. This Section 8 will survive any termination of these Terms of Use or your use of the Intelligence System. The undersigned hereby signs these Terms of Use. By electronically signing and clicking "Accept" below, these Terms of Use will be legally binding on me. To sign these Terms of Use, confirm your full name and enter your User ID and Password (as your electronic signature) in the fields indicated below and click the “I Accept” button.

Reset Your Password

Financial Professionals*

Your password must be a minimum of characters.

Confirmation Message

Your LordAbbett.com password was successully updated. This page will be refreshed after 3 seconds.

OK

 

Fixed-Income Insights

Will the impact of the U.S. Federal Reserve’s reduction of bond purchases really be “like watching paint dry”?

 

In Brief

  • Are investors too complacent about the potential impact of the U.S. Federal Reserve’s (Fed) efforts to normalize its balance sheet, expected to begin in October?
  • While Fed officials have played down the potential impact of its plans to reduce monthly purchases of U.S. Treasuries and mortgage-backed securities (MBS), the move could introduce some volatility in financial markets.
  • How? The reductions increase significantly over the Fed’s contemplated time frame. Since the Fed has helped absorb demand for available Treasuries, its reduced role in the market could pressure yields higher.
  • Further, reduced purchases of MBS could result in wider spreads, and higher mortgage rates, pressuring the U.S. housing sector.
  • Developments on the economic, political, and market fronts during the Fed’s contemplated launch of normalization in October also may contribute to market volatility and investor reaction.
  • The key takeaway: The rollout of the Fed’s balance-sheet normalization effort may have a greater market impact than investors currently believe.

 

Normalization of the U.S. Federal Reserve’s (Fed) balance sheet seems likely to begin in October. This long-awaited reduction in securities purchases, referred to as qualitative tightening (QT), could unfold even as low inflation potentially delays an interest-rate hike projected for December.

With the move frequently discussed by Fed chair Janet Yellen and other officials of the central bank, investors seem complacent about the consequences of a gradual reduction of the Fed’s bond portfolio. (The Fed first began purchasing bonds as part of an economic stimulus effort in December 2008.) According to Bloomberg, 10-year U.S. Treasury yields actually are lower since the Fed described its balance-sheet normalization plan on June 14, 2017. Is the reduction in Fed holdings of Treasuries and mortgage-backed securities (MBS) the non-event the Fed portrays—or could the process produce a “tightening tantrum” in the market that pressures longer-term rates higher, widens MBS spreads, and steepens the yield curve? 

The difference between the market’s current benign expectations and a more volatile result could be influenced by other concerns in October, including equity valuations, congressional debt-limit debates, and a potential shift in European monetary policy. Analysis suggests that investors should be on guard for more volatility in the markets than implied by the recent stability in 10-year Treasury yields.  

Back to Normal
The plan by the Fed’s policy-setting arm, the Federal Open Market Committee (FOMC), to normalize its $4.4 trillion balance sheet was described in a communiqué released after its meeting on June 14. Although no start date was identified (the release characterized it as “relatively soon”), and no specific portfolio size was targeted, the plan detailed the size and subsequent increases in monthly portfolio reductions that investors can expect. Reinvestment of portfolio principal initially will be reduced by $10 billion per month, for the first three months, increasing by $10 billion per month for each of the next four quarters, until reinvestments are reduced by $50 billion per month.

The initial $10 billion target will be achieved by reductions of $6 billion in Treasury purchases and $4 billion in purchases of MBS.  By the end of the first 12 months of the program, the Fed will have reduced its purchases by a cumulative total of $300 billion—$180 billion in Treasury securities and $120 billion in MBS. The second year, and those subsequent, would reflect purchase reductions of $600 billion per year: $360 billion in Treasuries and $240 billion in MBS.

While the initial reductions of $10 billion per month may seem relatively minor, the 12-month ramp up to $50 billion per month quickly becomes meaningful, especially the $30 billion in reduced Treasury purchases. The latter figure compares with recent U.S. Treasury 10-year auctions that have averaged $21 billion per month. The seven-year and five-year auctions have averaged $28 billion and $34 billion, respectively. Although the Fed’s purchases are in the secondary market, not at Treasury auctions, assuming the Fed maintains a Treasury portfolio with about 40% in securities above five-year maturities, the absence of the Fed’s purchasing power seems likely to have some impact on five- to 10-year yields. The securities with maturities that the Fed currently purchases will have to be purchased by other investors, most likely at higher yields. Such impact could be dampened by skewing U.S. Treasury supply toward shorter maturities, but this strategy has not been suggested by either Treasury or the Fed. A reduction in the Fed’s Treasury purchases seems likely to produce some yield-curve steepening.

Mortgage Spillover
Perhaps a more meaningful impact will be felt in the MBS market. The immediate reduction of $4 billion per month in Fed purchases may be easily absorbed, but the $20 billion monthly reduction a year later could have greater consequences. Total new issuance of agency MBS averaged $134 billion per month in 2016, according to the Securities Industry and Financial Markets Association. 

The absence of the Fed’s $20 billion per month in purchasing power—equivalent to 15% of recent new issue supply—could produce some yield-spread widening between agency MBS and U.S. Treasuries of comparable maturity. An increase in MBS yields would likely pull mortgage rates higher as well, weighing on the U.S. housing sector in the process.

Thus, although the Fed’s initial pace of balance-sheet slimming seems very manageable, the prospect of persistent increases in the rate of reduction could at some point produce investor concern. That concern could be mitigated by other factors affecting yields on Treasuries and MBS, or it could happen rapidly in the form of a “tightening tantrum,” pressuring bond prices lower and yields higher. Regardless of investor reaction, the normalization of the Fed’s balance sheet seems likely to be “noisier” than the uneventful outcome suggested by Fed officials, and potentially a much different experience than the “like watching paint dry” comparison offered by Chairwoman Yellen.

Watching October
Developments on the economic, political, and market fronts during October also may contribute to market volatility and investor reaction. U.S. congressional debate on federal debt limits could increase investor angst, as well as a decision at that time by the European Central Bank to reduce its own level of quantitative easing. Increases in announced inflation by that time also could boost the likelihood of a Fed rate hike in December. As of August 18, fed funds futures data from Bloomberg suggested that investors saw only a 37% probability of a hike. 

And, finally, U.S. equity valuations also may play a role in investor reaction. To the extent investors believe that equity valuations have been fueled by years of quantitative easing, while yields have been pushed to artificially low levels, it may be difficult to persuade investors that the opposite policy—quantitative tightening—will have no meaningful market impact. Given the size of eventual balance-sheet reduction and potentially volatile environment at the time the Fed’s normalization is expected to launch, it is not unreasonable, at least in our view, to expect that the central bank’s efforts to reduce the pace of security purchases may differ from Yellen’s hopeful characterization of a process “that runs quietly in the background.”

 

About The Author

Please confirm your literature shipping address

Please review the address information below and make any necessary changes.

All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

Current Literature Shipping Address

* Required field